Overview

Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
to demonstrate the efficacy of inhaled Technosphere/Insulin in combination with metformin versus combination metformin and a secretagogue
Phase:
Phase 3
Details
Lead Sponsor:
Mannkind Corporation
Treatments:
Hypoglycemic Agents
Insulin
Insulin, Globin Zinc
Metformin
Secretagogues